Furthermore, our investigation uncovered an additional negative association between CDL and soluble Aβ42 level (r = −0.33; p = 0.014), which was decreased due to its aggregation to form poorly soluble oligomers in AD (Figure 5I). Here, SGMS2 is linked to Alzheimer disease.